Consensus
The community sees this as very unlikely for AstraZeneca at 18%, based on 7 forecasts. Forecasters are in moderate agreement.
Resolves YES if AstraZeneca closes at or above $200 at any point in the next 3 months.
Share your read on this question — the best forecasters show their work.
See the whole azn discussion →